How To Detect NDM-1 Producers

被引:283
作者
Nordmann, Patrice [1 ]
Poirel, Laurent [1 ]
Carrer, Amelie [1 ]
Toleman, Mark A. [2 ]
Walsh, Timothy R. [2 ]
机构
[1] Hop Bicetre, Serv Bacteriol Virol, INSERM,Fac Med Paris Sud, Emerging Resistance Antibiot U914,AP HP, F-94275 Le Kremlin Bicetre, France
[2] Cardiff Univ, Dept Immunol Immun & Biochem, Sch Med, Cardiff, S Glam, Wales
关键词
BETA-LACTAMASE; CARBAPENEMASES; RESISTANCE; EMERGENCE;
D O I
10.1128/JCM.01773-10
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Enterobacterial isolates expressing the carbapenemase NDM-1 are emerging worldwide. Twenty-seven NDM-1-positive isolates of worldwide origin were included in this study to identify these strains as not only pathogens but also colonizers of normal flora for infection control screening. Although susceptibility to carbapenems varied, a combined test (IMP/IMP + EDTA), the Etest MBL, and automated susceptibility testing by Vitek2 (bioMerieux) identified those NDM-1 producers as verified by PCR using specific primers. Screening for carriers of NDM-1 producers may be based on media such as the ChromID ESBL culture medium routinely used to screen for extended-spectrum beta-lactamase producers, which gives excellent detection levels with low limits of detection ranging from 8 x 10(0) to 5 x 10(2) CFU/ml. The CHROMagar KPC culture medium had higher limits of detection (1 x 10(1) to 5 x 10(5) CFU/ml) and may be proposed for the follow-up of outbreaks of infections with NDM-1 producers. Colonies growing on these screening media can be verified as NDM-1 producers with molecular methods as described herein.
引用
收藏
页码:718 / 721
页数:4
相关论文
共 18 条
[1]  
Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P750
[2]   Use of ChromID Extended-Spectrum β-Lactamase Medium for Detecting Carbapenemase-Producing Enterobacteriaceae [J].
Carrer, Amelie ;
Fortineau, Nicolas ;
Nordmann, Patrice .
JOURNAL OF CLINICAL MICROBIOLOGY, 2010, 48 (05) :1913-1914
[3]  
Clinical and Laboratory Standards Institute, 2010, M100S20U CLSI
[4]  
Deshpande Payal, 2010, J Assoc Physicians India, V58, P147
[5]   Phenotypic detection of carbapenem-susceptible metallo-β-lactamase-producing gram-negative bacilli in the clinical laboratory [J].
Franklin, Clare ;
Liolios, Lisa ;
Peleg, Anton Y. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (09) :3139-3144
[6]   Coexistence of blaOXA-23 with blaNDM-1 and armA in clinical isolates of Acinetobacter baumannii from India [J].
Karthikeyan, Kumarasamy ;
Thirunarayan, M. A. ;
Krishnan, Padma .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (10) :2253-2254
[7]   Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study [J].
Kumarasamy, Karthikeyan K. ;
Toleman, Mark A. ;
Walsh, Timothy R. ;
Bagaria, Jay ;
Butt, Fafhana ;
Balakrishnan, Ravikumar ;
Chaudhary, Uma ;
Doumith, Michel ;
Giske, Christian G. ;
Irfan, Seema ;
Krishnan, Padma ;
Kumar, Anil V. ;
Maharjan, Sunil ;
Mushtaq, Shazad ;
Noorie, Tabassum ;
Paterson, David L. ;
Pearson, Andrew ;
Perry, Claire ;
Pike, Rachel ;
Rao, Bhargavi ;
Ray, Ujjwayini ;
Sarma, Jayanta B. ;
Sharma, Madhu ;
Sheridan, Elizabeth ;
Thirunarayan, Mandayam A. ;
Turton, Jane ;
Upadhyay, Supriya ;
Warner, Marina ;
Welfare, William ;
Livermore, David M. ;
Woodford, Neil .
LANCET INFECTIOUS DISEASES, 2010, 10 (09) :597-602
[8]  
Lledo W., 2009, Morbidity and Mortality Weekly Report, V58, P256
[9]   Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues [J].
Miriagou, V. ;
Cornaglia, G. ;
Edelstein, M. ;
Galani, I. ;
Giske, C. G. ;
Gniadkowski, M. ;
Malamou-Lada, E. ;
Martinez-Martinez, L. ;
Navarro, F. ;
Nordmann, P. ;
Peixe, L. ;
Pournaras, S. ;
Rossolini, G. M. ;
Tsakris, A. ;
Vatopoulos, A. ;
Canton, R. .
CLINICAL MICROBIOLOGY AND INFECTION, 2010, 16 (02) :112-122
[10]   The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria [J].
Nordmann, Patrice ;
Cuzon, Gaelle ;
Naas, Thierry .
LANCET INFECTIOUS DISEASES, 2009, 9 (04) :228-236